相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Uric Acid Potential Role in Systemic Inflammation and Negative Symptoms After Acute Antipsychotic Treatment in Schizophrenia
Milica M. Borovcanin et al.
FRONTIERS IN PSYCHIATRY (2022)
Blood-based oxidation markers in medicated and unmedicated schizophrenia patients: A meta-analysis
Xue Xin Goh et al.
ASIAN JOURNAL OF PSYCHIATRY (2022)
The Influence of Serum Uric Acid on the Brain and Cognitive Dysfunction
Natasa R. Mijailovic et al.
FRONTIERS IN PSYCHIATRY (2022)
Anticholinergic Medication Burden-Associated Cognitive Impairment in Schizophrenia
Yash B. Joshi et al.
AMERICAN JOURNAL OF PSYCHIATRY (2021)
Association between body mass index, its change and cognitive impairment among Chinese older adults: a community-based, 9-year prospective cohort study
Shanshan Wu et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2021)
Interaction of oxidative stress and BDNF on executive dysfunction in patients with chronic schizophrenia
ChangWei Wei et al.
PSYCHONEUROENDOCRINOLOGY (2020)
Cognitive Impairment in Never-Medicated Individuals on the Schizophrenia Spectrum
Rodolfo Solis-Vivanco et al.
JAMA PSYCHIATRY (2020)
The association between serum uric acid level and the risk of cognitive impairment after ischemic stroke
Jing Sun et al.
NEUROSCIENCE LETTERS (2020)
Uric acid levels in subjects with schizophrenia: A systematic review and meta-analysis
Qiuxing He et al.
PSYCHIATRY RESEARCH (2020)
Role of comorbidities in heart failure prognosis Part 2: Chronic kidney disease, elevated serum uric acid
Andrea Tedeschi et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2020)
Insulin Resistance and Oxidative Stress: In Relation to Cognitive Function and Psychopathology in Drug-Naive, First-Episode Drug-Free Schizophrenia
Qi Tao et al.
FRONTIERS IN PSYCHIATRY (2020)
Increased Cerebrospinal Fluid Uric Acid Levels in Guillain-Barre Syndrome
Sheng-Hui Chang et al.
FRONTIERS IN NEUROLOGY (2020)
Urate and risk of Alzheimer's disease and vascular dementia: A population-based study
Lieke E. J. M. Scheepers et al.
ALZHEIMERS & DEMENTIA (2019)
Early Identification and Intervention of Schizophrenia: Insight From Hypotheses of Glutamate Dysfunction and Oxidative Stress
Chieh-Hsin Lin et al.
FRONTIERS IN PSYCHIATRY (2019)
Anticholinergic Drug Exposure and the Risk of Dementia: A Nested Case-Control Study
Carol A. C. Coupland et al.
JAMA INTERNAL MEDICINE (2019)
Quantitative Subcellular Proteomics of the Orbitofrontal Cortex of Schizophrenia Patients
Erika Velasquez et al.
JOURNAL OF PROTEOME RESEARCH (2019)
Mitochondria, Metabolism, and Redox Mechanisms in Psychiatric Disorders
Yeni Kim et al.
ANTIOXIDANTS & REDOX SIGNALING (2019)
Cognitive impairment in psychotic illness: prevalence, profile of impairment developmental course, and treatment considerations
Amanda McCleery et al.
DIALOGUES IN CLINICAL NEUROSCIENCE (2019)
Comparative effects of aripiprazole and selected antipsychotic drugs on lipid peroxidation in plasma
Anna Dietrich-Muszalska et al.
PSYCHIATRY AND CLINICAL NEUROSCIENCES (2018)
Elevated cerebrospinal fluid uric acid during relapse of neuromyelitis optica spectrum disorders
Yaqing Shu et al.
BRAIN AND BEHAVIOR (2017)
Reducing Anticholinergic Medication Burden in Patients With Psychotic or Bipolar Disorders
Ana M. Lupu et al.
JOURNAL OF CLINICAL PSYCHIATRY (2017)
Uric acid demonstrates neuroprotective effect on Parkinson's disease mice through Nrf2-ARE signaling pathway
Ting-Ting Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Accelerated Gray and White Matter Deterioration With Age in Schizophrenia
Vanessa L. Cropley et al.
AMERICAN JOURNAL OF PSYCHIATRY (2017)
Serum uric acid level and association with cognitive impairment and dementia: systematic review and meta-analysis
Aamir A. Khan et al.
AGE (2016)
Performance of Mini-Mental State Examination (MMSE) in long-stay patients with schizophrenia or schizoaffective disorders in a psychiatric institute
Hui Lin Ong et al.
PSYCHIATRY RESEARCH (2016)
Uric acid correlates to oxidation and inflammation in opposite directions in women
Sheng Hui Wu et al.
BIOMARKERS (2015)
Serum Uric Acid and Subsequent Cognitive Performance in Patients with Pre-Existing Cardiovascular Disease
Noa Molshatzki et al.
PLOS ONE (2015)
Treatments of Negative Symptoms in Schizophrenia: Meta-Analysis of 168 Randomized Placebo-Controlled Trials
Paolo Fusar-Poli et al.
SCHIZOPHRENIA BULLETIN (2015)
Oxidative stress and mitochondrial dysfunction in Alzheimer's disease
Xinglong Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2014)
Nrf2 Signaling Contributes to the Neuroprotective Effects of Urate against 6-OHDA Toxicity
Ning Zhang et al.
PLOS ONE (2014)
Estrogen receptor α gene polymorphisms and risk of Alzheimer's disease: evidence from a meta-analysis
Daye Cheng et al.
CLINICAL INTERVENTIONS IN AGING (2014)
Long-term anticholinergic use and the aging brain
Xueya Cai et al.
ALZHEIMERS & DEMENTIA (2013)
Association of serum uric acid level with muscle strength and cognitive function among Chinese aged 50-74 years
Yili Wu et al.
GERIATRICS & GERONTOLOGY INTERNATIONAL (2013)
Antioxidants as potential therapeutics for neuropsychiatric disorders
Chirayu D. Pandya et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Free radicals, antioxidant defense systems, and schizophrenia
Jing Qin Wu et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2013)
Serum uric acid levels and the clinical characteristics of depression
Shenglin Wen et al.
CLINICAL BIOCHEMISTRY (2012)
Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents
S. Miyamoto et al.
MOLECULAR PSYCHIATRY (2012)
Oxidative Stress in Schizophrenia
Iztok Grabnar et al.
Current Neuropharmacology (2011)
Anticholinergic Medication Use and Cognitive Impairment in the Older Population: The Medical Research Council Cognitive Function and Ageing Study
Chris Fox et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2011)
Is there anything good in uric acid?
B. Alvarez-Lario et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2011)
Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
Marc De Hert et al.
WORLD PSYCHIATRY (2011)
Association of cognitive function with serum uric acid level among Chinese nonagenarians and centenarians
Jun Li et al.
EXPERIMENTAL GERONTOLOGY (2010)
Homeostatic Imbalance of Purine Catabolism in First-Episode Neuroleptic-Naive Patients with Schizophrenia
Jeffrey K. Yao et al.
PLOS ONE (2010)
Serum uric acid and cognitive function and dementia
S. M. Euser et al.
BRAIN (2009)
Total Antioxidant Status at High Altitude in Lowlanders and Native Highlanders: Role of Uric Acid
Sanchari Sinha et al.
HIGH ALTITUDE MEDICINE & BIOLOGY (2009)
Lifetime prevalence of psychotic and bipolar I disorders in a general population
Jonna Perala et al.
ARCHIVES OF GENERAL PSYCHIATRY (2007)
Leptin facilitates learning and memory performance and enhances hippocampal CA1 long-term potentiation and CaMK II phosphorylation in rats
Y. Oomura et al.
PEPTIDES (2006)
Meta-analysis of the Brief Psychiatric Rating Scale factor structure
A Shafer
PSYCHOLOGICAL ASSESSMENT (2005)
Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients
M Arvindakshan et al.
BIOLOGICAL PSYCHIATRY (2003)
Functional capacity and self-evaluation of health and life of oldest old in China
Z Yi et al.
JOURNAL OF SOCIAL ISSUES (2002)
Systemic uric acid administration increases serum antioxidant capacity in healthy volunteers
WS Waring et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2001)
Experimental meningitis in the rat: protection by uric acid at human physiological blood concentrations
S Kastenbauer et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Abnormal age-related changes of plasma antioxidant proteins in schizophrenia
JK Yao et al.
PSYCHIATRY RESEARCH (2000)
Reaction of uric acid with peroxynitrite and implications for the mechanism of neuroprotection by uric acid
GL Squadrito et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2000)
Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation, blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis
DC Hooper et al.
FASEB JOURNAL (2000)